Cognex® (
tacrine hydrochloride) is a prescription medication approved for the treatment of mild to moderate
Alzheimer's disease. It belongs to a group of medications known as acetylcholinesterase inhibitors.
- Confusion
- Deterioration of language skills
- Memory loss
- Poor judgment
- Impaired ability to understand visual information
- Mood swings
- Restlessness.
The recommended
Alzheimer's treatment varies depending on the different
stages of Alzheimer's.
Alzheimer's disease medications are usually central to the treatment of Alzheimer's. Cognex has been approved for the treatment of mild to moderate Alzheimer's disease. It is not a cure for Alzheimer's, nor does it alter the course of the disease or
prevent Alzheimer's from occurring. It can, however, help improve memory, attention, reason, language, and the ability to perform simple daily tasks.